Specific immunotherapy: One size does not fit all

Nature Medicine

Volumn 6, Issue 10, 2000, Pages 1098-1100

  Genain, C P ^a   Zamvil, S S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALITIS; AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG SAFETY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SHORT SURVEY; THEORY;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; IMMUNOTHERAPY; LIGANDS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; TH1 CELLS; TH2 CELLS;

EID: 0033786591     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/80424     Document Type: Short Survey

References (21)

1. The T-lymphocyte in experimental allergic encephalomyelitis
2. T cell recognition as the target for immune intervention in autoimmune disease
3. T cell recognition of self and altered self antigens
4. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
5. Encephalitogenic potential of myelin basic protein peptide (amino acid 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
6. The discovery of MHC restriction
7. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
8. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
9. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand
10. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry
11. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens
12. Immunological aspects of demyelinating diseases
13. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
14. Identification of autoantibodies associated with myelin damage in multiple sclerosis
15. Late complications of immune deviation therapy in a non human primate
16. Molecular mimicry in T ceil mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
17. Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity
18. Variant TCR ligands: New insights into the molecular basis of antigen-dependent signal transduction and T cell activation
19. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones
20. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
21. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking